LifeSci Venture Partners
Seed to Series B venture capital firm
LifeSci Venture Partners is a Seed to Series B venture capital firm that typically writes $500K–$15M checks in Biotechnology, Medical Devices and Digital Health. DryPowder has no SEC Form D on file for LifeSci Venture Partners as of September 12, 2026. Partners at LifeSci Venture Partners include Bruce Booth (Partner).
Updated · Sources: fund website
- Typical check
- $500K–$15M
- Stages
- Seed–Series B
Overview
LifeSci Venture Partners at a glance
- Stage
- Seed, Series A, Series B
- Check size
- $500K–$15M
- Sectors
- Biotechnology, Medical Devices, Digital Health, Pharmaceuticals
- Website
- lifescivc.com
Investment thesis
Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies
Stated on lifescivc.comWEBSITE
Partners
1 partner at LifeSci Venture Partners
- Bruce Booth
Partner · biotech, life sciences
Similar funds
Funds like LifeSci Venture Partners
M13AI/ML, Enterprise Software · $500K–$10M
1984 VenturesAI/ML, Dev Tools
3one4 CapitalSaaS, Consumer Internet
Flagship PioneeringBiotechnology, Genetic Medicine
IndieBioClimate, Healthcare · $100K–$500K
Investor lists that include LifeSci Venture Partners
FAQ
Questions about LifeSci Venture Partners
What does LifeSci Venture Partners invest in?
LifeSci Venture Partners is a Seed, Series A, Series B stage Biotechnology, Medical Devices, Digital Health, Pharmaceuticals investor, typically writing $500K – $15M checks, primarily investing in United States. Their thesis: Invests in early-stage life sciences companies developing breakthrough therapeutics, medical devices, and healthcare technologies
What check size does LifeSci Venture Partners write?
LifeSci Venture Partners typically writes $500K – $15M checks at the Seed, Series A, Series B stage in Biotechnology, Medical Devices, Digital Health, Pharmaceuticals.
What other funds are similar to LifeSci Venture Partners?
Funds with an overlapping stage and sector focus include M13, 1984 Ventures, 3one4 Capital.
Sources
Updated